BerGenBio AS (BRRGF)

BerGenBio AS (BRRGF) Cash flow


BerGenBio AS Cash Flow

BRRGF's free cash flow for Q1 2023 was kr4.35M. For the 2023 fiscal year, BRRGF's free cash flow was decreased by kr-13.37M and operating cash flow was kr4.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
kr -110.20Mkr 90.03Mkr 95.72Mkr -234.29Mkr -186.68Mkr -186.71M
Investing Cash Flow
kr 273.07Mkr -706.89Mkr -207.35Mkr 3.55Mkr 2.21Mkr -228.00K
Financing Cash Flow
kr -128.56Mkr -157.54Mkr 468.80Mkr 699.51Mkr 77.32Mkr 177.00M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
kr 996.05Mkr 145.31Mkr 919.71Mkr 721.64Mkr 253.59Mkr 360.41M
Income Tax Paid Supplemental Data
kr 7.19Mkr 7.19Mkr 15.72M---
Interest Paid Supplemental Data
kr 16.93Mkr 16.93Mkr 16.37M---
Issuance Of Capital Stock
---kr 740.85Mkr 82.78Mkr 190.53M
Issuance Of Debt
kr 204.91Mkr -176.00Kkr -187.00K---
Repayment Of Debt
kr 204.91Mkr -176.00Kkr -187.00K---
Free Cash Flow
kr -120.31Mkr 75.22Mkr 88.59Mkr -234.36Mkr -186.68Mkr -186.93M
Domestic Sales
Foreign Sales
Currency in NOK

BerGenBio AS Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis